Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation

Eye

Volumn 25, Issue 7, 2011, Pages 860-865

  Kamoi, M ^a   Ogawa, Y ^a   Uchino, M ^a   Tatematsu, Y ^a   Mori, T ^a   Okamoto, S ^a   Tsubota, K ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

allogeneic hematopoietic stem cell transplantation; chronic graft vs host disease; dry eye; gender mismatched transplantation; minor histocompatibility antigens

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; DRY EYE; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RECIPIENT; SEX DIFFERENCE;

EID: 79960444353     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.73     Document Type: Article

References (26)

1. Arai S, Vogelsang GB. Management of graft-versus-host disease. Blood Rev 2000; 14: 190-204. (Pubitemid 32098008)
2. Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062-2068.
3. Sullivan KM. Graft-vs-host disease. In: Blume KG, Forman SJ, Applebaum FR (eds). Thomas Hematopoietic Cell Transplantation. 3rd edn. Blackwell: Malden, MA, 2004, pp 635-664.
4. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003; 22: S19-S27. (Pubitemid 37169601)
5. Bross DS, Tutschka PJ, Farmer ER, Beschorner WE, Braine HG, Mellitis ED et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood 1984; 63: 1265-1270. (Pubitemid 14120367)
6. Randolph SSB, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graftversus- leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103: 347-352. (Pubitemid 38029959)
7. Gale RP, Bortin MM, Bekkum DW, Biggs JC, Dicke KA, Gluckman E et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397-406. (Pubitemid 18032036)
8. Stern M, Brand R, Witte T, Sureda A, Rocha V, Passweg J et al. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant 2008; 8: 2149-2157.
9. Gratwohl A, Hermans J, Niederwieser D, Biezen A, Houwelingen HC, Apperley J. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2001; 2: 363-370. (Pubitemid 34048659)
10. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea 1993; 12: 366-367.
11. Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of dry eye syndrome. Cornea 1994; 13(3): 202-209. (Pubitemid 24129152)
12. Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol 1995; 79: 1007-1011.
13. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21: 221-232.
14. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969; 82: 10-14.
15. Ban Y, Ogawa Y, Goto E, Uchino M, Terauchi N, Seki M et al. Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host disease. Eye 2009; 23: 202-208.
16. Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol 1991; 111: 106-108.
17. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 75-92.
18. Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010; 45: 1388-1395.
19. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007; 40: 381-387. (Pubitemid 47202424)
20. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
21. Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004; 103: 353-359. (Pubitemid 38035116)
22. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005; 105: 2973-2978. (Pubitemid 40446295)
23. Flowers ME, Pepe MS, Longton G, Doney KC, Monroe D, Witherspoon RP et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol 1990; 74(4): 492-496. (Pubitemid 20122752)
24. Kollman C, Howe CWS, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043-2051.
25. Carlens S, Ringden O, Remberger M, Lonnqvist B, Hagglund H, Klaesson S et al. Risk factors for chronic graftversus- host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998; 22: 755-761. (Pubitemid 28488318)
26. Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465-1470. (Pubitemid 29380428)